134 related articles for article (PubMed ID: 2807601)
1. Optimization of heparinization in clinical double filtration plasmapheresis.
Hosokawa S; Oyamaguchi A; Yoshida O
Int J Artif Organs; 1989 Aug; 12(8):544-8. PubMed ID: 2807601
[TBL] [Abstract][Full Text] [Related]
2. Clinical studies on adequate dosage of heparin during immunoadsorption with membrane plasmapheresis.
Hosokawa S; Oyamaguchi A; Yoshida O
J Clin Apher; 1990; 5(4):197-200. PubMed ID: 2228999
[TBL] [Abstract][Full Text] [Related]
3. [The impact of heparin bolus from dysfunctional lumen of dual lumen central venous catheter on activated partial thromboplastin time during hemodialysis: is additional heparinization necessary?].
Sefer S; Kes P; Raić B; Heinrich B; Degoricija V; Szavits-Nossan J
Acta Med Croatica; 2006 Jun; 60(3):281-5. PubMed ID: 16933844
[TBL] [Abstract][Full Text] [Related]
4. Comparison of three modalities of plasmapheresis on coagulation: Centrifugal, single-membrane filtration, and double-filtration plasmapheresis.
Marlu R; Naciri Bennani H; Seyve L; Noble J; Chevallier E; Motte L; Imerzoukene F; Bugnazet M; Christophe M; Malvezzi P; Jouve T; Rostaing L
J Clin Apher; 2021 Jun; 36(3):408-419. PubMed ID: 33506958
[TBL] [Abstract][Full Text] [Related]
5. Regional Citrate Anticoagulation during Double-Filtration Plasmapheresis in Kidney Transplant Recipients: A Single-Center Retrospective Cohort Study.
Ho QY; Teh SP; Thangaraju S; Teo SH; Tan HK; Abdul Rahman MB; Ng LC; Lim AEL; Choong LHL; Kee T; Kaushik M;
Blood Purif; 2022; 51(4):376-382. PubMed ID: 34198288
[TBL] [Abstract][Full Text] [Related]
6. The impact of therapeutic plasma exchange and double filtration plasmapheresis on hemostasis in renal transplant recipients.
Vatazin AV; Zulkarnaev AB
Ter Arkh; 2018 Jun; 90(6):22-27. PubMed ID: 30701900
[TBL] [Abstract][Full Text] [Related]
7. Regional citrate anticoagulation vs systemic heparin anticoagulation for double-filtration plasmapheresis.
Teh SP; Ho QY; Kee YST; Thangaraju S; Tan RY; Teo SH; Tan HK; Tan CS; Choong HLL; Ng LC; Abdul Rahman M; Lim AEL; Kaushik M
J Clin Apher; 2023 Feb; 38(1):16-23. PubMed ID: 36197100
[TBL] [Abstract][Full Text] [Related]
8. Effect of double-filtration plasmapheresis for antibody-mediated rejection on hemostasis parameters and thrombin generation.
Marlu R; Malvezzi P; Seyve L; Jouve T; Maurizi J; Defendi F; Carron PL; Christophe M; Le Gouellec A; Polack B; Rostaing L
Thromb Res; 2018 Jun; 166():113-121. PubMed ID: 29747114
[TBL] [Abstract][Full Text] [Related]
9. [The resistance of activated partial thromboplastin time to heparin infusion during hemodialysis].
Camici M; Sagripanti A; Barsotti G; Baicchi U; Evangelisti L; Morelli E; Giovannetti S
Minerva Med; 1995 Sep; 86(9):353-5. PubMed ID: 7501225
[TBL] [Abstract][Full Text] [Related]
10. Clinical efficacy of centrifugal-membranous hybrid double filtration plasmapheresis and membranous double filtration plasmapheresis on severe lupus nephritis.
Dong J; Huang L; Li C; Wu B; Yang X; Ge Y
Lupus; 2023 Aug; 32(9):1066-1074. PubMed ID: 37487569
[TBL] [Abstract][Full Text] [Related]
11. Comparison of double-filtration plasmapheresis (DFPP) versus heparin-mediated extracorporeal LDL-precipitation (HELP)-apheresis in early-onset preeclampsia.
Winkler K; Lorey C; Contini C; Augustinski V; Pütz G; Röthele E; Benner A; Fuchs H; Pecks U; Markfeld-Erol F; Kunze M
Pregnancy Hypertens; 2024 Jun; 36():101128. PubMed ID: 38728925
[TBL] [Abstract][Full Text] [Related]
12. Clinical evaluation of nafamstat mesilate (FUT 175). A new anticoagulant for plasmapheresis.
Hosokawa S; Oyamaguchi A; Yoshida O
ASAIO J; 1992; 38(1):59-60. PubMed ID: 1554918
[TBL] [Abstract][Full Text] [Related]
13. Double filtration plasmapheresis can decrease factor XIII Activity.
Hanafusa N; Kondo Y; Suzuki M; Nakao A; Noiri E; Fujita T
Ther Apher Dial; 2007 Jun; 11(3):165-70. PubMed ID: 17497996
[TBL] [Abstract][Full Text] [Related]
14. How to improve clotting factors depletion in double-filtration plasmapheresis.
Naciri Bennani H; Marlu R; Terrec F; Motte L; Seyve L; Chevallier E; Malvezzi P; Jouve T; Rostaing L; Noble J
J Clin Apher; 2021 Oct; 36(5):766-774. PubMed ID: 34339059
[TBL] [Abstract][Full Text] [Related]
15. Double filtration plasmapheresis for children with different types of critical kidney diseases: a single-center retrospective cohort study.
Zhang Y; Xie Q; Chen Y; Yang J; Huang S; Deng L; Zhou J
Transl Pediatr; 2023 Mar; 12(3):354-363. PubMed ID: 37035407
[TBL] [Abstract][Full Text] [Related]
16. A controlled study of double filtration plasmapheresis in the treatment of active rheumatoid arthritis.
Yu X; Ma J; Tian J; Jiang S; Xu P; Han H; Wang L
J Clin Rheumatol; 2007 Aug; 13(4):193-8. PubMed ID: 17762452
[TBL] [Abstract][Full Text] [Related]
17. Double filtration plasmapheresis in antibody-incompatible kidney transplantation.
Higgins R; Lowe D; Hathaway M; Lam FT; Kashi H; Tan LC; Imray C; Fletcher S; Chen K; Krishnan N; Hamer R; Zehnder D; Briggs D
Ther Apher Dial; 2010 Aug; 14(4):392-9. PubMed ID: 20649760
[TBL] [Abstract][Full Text] [Related]
18. Plasma exchange versus double filtration plasmapheresis in the treatment of Guillain-Barré syndrome.
Lyu RK; Chen WH; Hsieh ST
Ther Apher; 2002 Apr; 6(2):163-6. PubMed ID: 11982959
[TBL] [Abstract][Full Text] [Related]
19. More selective removal of myeloperoxidase-anti-neutrophil cytoplasmic antibody from the circulation of patients with vasculitides using a novel double-filtration plasmapheresis therapy.
Gong D; Ji D; Xu B; Liu Z
Ther Apher Dial; 2013 Feb; 17(1):93-8. PubMed ID: 23379500
[TBL] [Abstract][Full Text] [Related]
20. Study of plasma levels of soluble CD40 ligand in systemic lupus erythematosus patients who have undergone plasmapheresis.
Kimura K; Tsuda H; Kwangseok Y; Tamura N; Kanai Y; Kobayashi S
Ther Apher Dial; 2005 Feb; 9(1):64-8. PubMed ID: 15828909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]